Uphaar Cinema case verdict today

Uphaar Cinema

Sanjay Dutt to get TADA court judgment copy

HPV test better than Pap Smears for Cervical Cancer Detection

Cervical Cancer CellResearch has suggested that the detection of cervical cancer is more accurate using a blood test compared to Pap smears (Papanicolaou test). The study has suggested that HPV (Human Papilloma Virus) is found in 95% of cases of development of cervical cancer in cervix. The study published in the New England Journal of Medicine has suggested that individuals should directly go for HPV test instead of Pap smears.

October Print Edition Preview : Fourth Edition for October

Channel 4 ordered to hand over Princess Diana videos

Ricky Ponting for “different” approach in T20 format

Pages

News in Focus

Shriram Finance Share Price Target at Rs 1,200: ICICI Securities

ICICI Securities has maintained a BUY rating on Shriram Finance (SHRTRA) with a target price of Rs 1,200, implying an upside of ~19% from the current market price of Rs 1,011.

Crypto instead of Rupees: India’s Real-money Online Gaming ban boosts USDT demand and offshore Casino Growth

Since October 1, 2025, a nationwide ban on real-money online gaming has been in effect in India.

Sunteck Realty Share Price Target at Rs 520: Prabhudas Lilladher Stock Research

Sunteck Realty has delivered a robust operational and financial performance in FY26, reinforcing its positioning as a premium real estate developer in the Mumbai Metropolitan Region.

Cipla Share Price Target at Rs 1,550: ICICI Securities

ICICI Securities has upgraded Cipla to a BUY rating with a revised target price of Rs 1,550, implying a potential upside of nearly 19% from the current market price of Rs 1,306.

Tata Communications Share Price Target at Rs 2,100: ICICI Securities

ICICI Securities has reiterated its BUY call on Tata Communications, setting a revised target price of Rs 2,100, implying an upside potential of nearly 38% from the current market price of Rs 1,525

Infosys Share Price Target at Rs 1,497: Deven Choksey Research

Infosys, backed by a BUY recommendation from Deven Choksey Research, is entering a decisive phase where artificial intelligence moves from experimentation to real-world monetization.